title: Morning increase in platelet aggregability. Association with assumption of the upright posture.
abstract: The frequencies of onset of myocardial infarction and sudden cardiac death are increased between 6 AM and 12 noon. Platelet aggregability, which may play a role in the cause of these disorders, has been observed to increase after the normal morning activities of awakening, arising, and ambulating. To determine which morning activity or activities are responsible for this aggregability increase, we measured platelet aggregation in 16 normal subjects on a control day of delayed arising (i.e., subjects remained supine until 12:30 PM) and on a day in which normal morning activities were divided into three isolated components of awakening (8 AM), assumption of upright posture (9:30 AM), and ambulating (11 AM). Blood samples to assess platelet aggregability were drawn at 8 AM before activity and 90 minutes after the initiation of each activity (i.e., at 9:30 AM, 11 AM, and 12:30 PM). For the group, in vitro platelet responsiveness to adenosine diphosphate and epinephrine increased only after assumption of the upright posture. The lowest concentration of agonist required to produce biphasic platelet aggregation decreased (aggregability increased) between 9:30 and 11 AM (90 minutes after assumption of the upright posture) from 3.3 +/- 0.3 to 2.4 +/- 0.2 microM for adenosine diphosphate (p less than 0.05) and from 2.1 +/- 0.5 to 1.0 +/- 0.4 microM for epinephrine (p less than 0.05). During the same interval, plasma epinephrine increased from 34 +/- 7 to 55 +/- 9 pg/ml (p less than 0.05), and plasma norepinephrine increased from 169 +/- 19 to 298 +/- 25 pg/ml (p less than 0.01). There was no significant change in aggregability or catecholamine concentrations on the control day.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.
authors.forename: D A
authors.initials: DA
authors.lastname: Brezinski
authors.forename: G H
authors.initials: GH
authors.lastname: Tofler
authors.forename: J E
authors.initials: JE
authors.lastname: Muller
authors.forename: S
authors.initials: S
authors.lastname: Pohjola-Sintonen
authors.forename: S N
authors.initials: SN
authors.lastname: Willich
authors.forename: A I
authors.initials: AI
authors.lastname: Schafer
authors.forename: C A
authors.initials: CA
authors.lastname: Czeisler
authors.forename: G H
authors.initials: GH
authors.lastname: Williams
mesh_terms: D000203:Activities of Daily Living; D000244:Adenosine Diphosphate / Q000494:pharmacology; D000328:Adult; D000804:Angiotensin II / Q000097:blood; D002940:Circadian Rhythm; D004837:Epinephrine / Q000097:blood / Q000494:pharmacology; D006400:Hematocrit; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D009638:Norepinephrine / Q000097:blood; D010974:Platelet Aggregation; D010976:Platelet Count; D011187:Posture; D012083:Renin / Q000097:blood
chemical_list: D000804:Angiotensin II; D000244:Adenosine Diphosphate; D012083:Renin; D009638:Norepinephrine; D004837:Epinephrine